The signing of a Memorandum of Understanding between Sami-Sabinsa Group and the Japan External Trade Organization sets the stage for Sabinsa's continued expansion in Japan.
Sreelal Mooliyil Mowanchery, Director, Sabinsa Japan Corporation and Tomohiro Takashima, Director General, Invest Japan Department. Image courtesy of Sabinsa.
The Sabinsa Japan Corp. (Tokyo, Japan), a division of Sami-Sabinsa Group (India), has signed a Memorandum of Understanding with the Japan External Trade Organization. The memorandum was signed on October 29, 2018, during the 13th India-Japan Annual Summit held between Indian Prime Minister Narendra Modi and Japan’s Prime Minister Shinzo Abe. The Memorandum of Understanding ensures Japan’s continued support of Sabinsa’s expansion in the country.
“As we continue our global expansion, we deeply appreciate the support of the Government of India and the trade development programs of the countries in which we do business, such as JETRO,” said Sabinsa founder Muhammed Majeed, PhD, in a press release. “Although we have had an office in Japan for some time, the support of the Government of Japan as we continue our investment in that country will allow us to more quickly make our products to enhance human health available on a wider scale to the people of Japan.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.